Tom Galli

Director/Board Member at LUNGevity Foundation

Consumer Services

Commercial Services

Profile

Tom Galli is currently the Director at LUNGevity Foundation since 2018.
He has an undergraduate degree from the University of Dayton and another undergraduate degree from Defense Systems Management College.

Tom Galli active positions

Companies	Position	Start
LUNGevity Foundation LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris.	Director/Board Member	2018-05-08

All active positions of Tom Galli

Training of Tom Galli

Defense Systems Management College	Undergraduate Degree
University of Dayton	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tom Galli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
LUNGevity Foundation LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris.	Commercial Services